Welcome to our dedicated page for Fonar news (Ticker: FONR), a resource for investors and traders seeking the latest updates and insights on Fonar stock.
Fonar Corporation (NASDAQ: FONR) is a medical device manufacturer and diagnostic imaging services company focused on magnetic resonance imaging (MRI). Company news releases highlight its role as "The Inventor of MR Scanning™" and describe how it designs, manufactures, sells and services MRI scanners while also managing MRI centers through its wholly owned subsidiary Health Management Company of America (HMCA). This news page aggregates announcements that relate directly to Fonar’s operations, technology and corporate actions.
Readers can find detailed coverage of Fonar’s periodic financial results, including quarterly and annual updates that discuss total revenues, income from operations, net income, cash and cash equivalents, working capital and scan volumes at HMCA-managed MRI centers. These releases often explain trends in MRI scan volume, the number of scanners managed in New York and Florida, and the impact of adding new scanners or centers to Fonar’s network.
Fonar’s news also frequently addresses developments in its MRI technology and service offerings. The company regularly describes the performance and use of its FONAR UPRIGHT® Multi-Position™ MRI (STAND-UP® MRI), which can scan patients in weight-bearing positions and is presented as a patient-friendly alternative to conventional lie-down scanners. Updates may include information on new high-field MRI installations at HMCA-managed centers and how combinations of STAND-UP® MRI and high-field systems affect scheduling and referral patterns.
Corporate governance and transaction-related announcements form another important part of Fonar’s news flow. In 2025 the company reported the receipt of non-binding and supplemental proposals from an acquisition group led by its chief executive officer to take the company private, followed by a definitive merger agreement providing for an all-cash acquisition of shares not owned by the group. News releases also cover board changes, such as director retirements and the appointment of an independent director with public accounting experience.
For investors and observers tracking FONR, this news stream provides primary-source information about Fonar’s financial performance, MRI center operations, product positioning, patent-related developments and the progress of its proposed going-private transaction. Regular updates help contextualize how the company’s MRI technology, HMCA-managed networks and capital markets activity evolve over time.
Summary not available.
Summary not available.
Summary not available.
FONAR Corporation (NASDAQ-FONR) reported financial results for the second quarter and six months ending December 31, 2020. Total revenues declined 2% to $42.1 million, while net income fell 18% to $7.2 million. However, net income for the latest quarter showed a 21% increase to $3.9 million compared to the previous quarter. Cash and cash equivalents rose 10% to $40.6 million. Operational challenges due to COVID-19 persist, but management anticipates a return to pre-pandemic scanning volumes. The company operates 38 managed MRI scanners and continues to invest in growth despite pandemic delays.
FONAR Corporation (FONR) has reported its first quarter fiscal 2021 results, revealing a 50% increase in MRI scan volume to 41,566 scans compared to the previous quarter, though down 13% year-over-year. Total revenues decreased 4% to $21 million, with net income down 28% to $3.3 million. SG&A expenses surged 44% due to COVID-19 related reserves. Cash and equivalents grew 5% to $38.8 million. Despite challenges, the company aims to resume pre-pandemic levels of operation and expects to install additional MRI scanners in the current fiscal year.
FONAR Corporation (NASDAQ-FONR) announced its inclusion in the Russell 3000® and Russell 2000® Indexes effective June 29, 2020. This milestone reflects the company's strong financial performance and aims to enhance visibility to investors. The Russell Indexes serve as benchmarks for approximately $9 trillion in assets, being widely used by investment managers and institutional investors. Founder and Chairman Raymond V. Damadian expressed pride in this recognition, highlighting a decade of improving operating performance.
FONAR Corporation (NASDAQ-FONR), known for pioneering MRI technology, has appointed Richard E. Turk as an independent director to its board, filling recent vacancies. This change follows the passing of board member Robert Janoff. CEO Timothy Damadian expressed optimism about Turk's background in expanding outpatient practices, as FONAR's growth is heavily linked to its subsidiary, Health Management Company of America. Turk's experience includes significant acquisition successes at PRISM Vision Group and Professional Physical Therapy, enhancing prospects for FONAR’s development.
FONAR Corporation (NASDAQ-FONR) reported a 5% decline in total revenues to $21.7 million for the third quarter ended March 31, 2020, due to COVID-19 impacts. Net income fell to $1.9 million, down from $5.2 million in the previous year. However, cash and cash equivalents were robust at $31.0 million. The pandemic caused significant delays in MRI scanner installations, now expected in Q1 FY 2021, increasing total units managed to 39. Management remains optimistic about recovery as states begin reopening, anticipating improved scan volumes in the upcoming quarters.